Trials / Completed
CompletedNCT00984633
Study of Efficacy, Pharmacokinetics, and Safety of Bolus Maintenance Doses of Org 9426 (Study P05976)(COMPLETED)
Study of Efficacy, Pharmacokinetics, and Safety of Bolus Maintenance Doses of Org 9426 Following a Single Intubating Dose in Adult Subjects Undergoing Operation Under Sevoflurane or Propofol Anesthesia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- 20 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy, pharmacokinetics, and safety of Org 9426 in maintenance of muscle relaxation in adult subjects undergoing general elective surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rocuronium bromide (Org 9426) | 0.6 mg/kg injection intubation dose |
| DRUG | Rocuronium bromide (Org 9426) | 0.9 mg/kg injection intubation dose |
| DRUG | Sevoflurane | 0.5-2.0% intravenous maintenance anesthesia |
| DRUG | Propofol | 4-10 mg/kg/hr maintenance anesthesia |
Timeline
- Start date
- 2003-06-01
- Primary completion
- 2003-12-01
- Completion
- 2003-12-01
- First posted
- 2009-09-25
- Last updated
- 2015-05-12
Source: ClinicalTrials.gov record NCT00984633. Inclusion in this directory is not an endorsement.